logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Repros Jumps on Positive Drug Trials

By  +Follow September 17, 2013 8:01AM
Share:
Tickers Mentioned:

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on. The spike, driven by positive topline results from the most recent study on its drug Androxal® reported after close on Monday, pushed Repros stock to a new 52-week high.

Positive results for Androxal

Androxal is being developed for men of reproductive age with low testosterone due to secondary hypogonadism, which is also associated with obesity and could be among the most common causes of low testosterone. Repros reported that Andorxal met both co-primary endpoints in its second pivotal study, with 81 percent of subjects using the drug experiencing normalized testosterone and no 24-hour average testosterone levels outside of normal ranges. Androxal, which is in a class similar to Sanofi’s (SNY) Clomid®, could receive a strong share of the testosterone replacement therapy (TRT) market because it could also help preserve male fertility while being administered orally, making it significantly more convenient than testosterone replacement injections.  

Possible Sale

Brean Capital initiated coverage of Repros in July of this year, calling it a buy and setting a price target of $32. At the time, analyst Jonathan Aschoff said “Its lead compound Androxal is being evaluated in a Phase 3 program for secondary hypogonadism with results in 4Q13 and 2Q14, which in our view would be key investment catalysts, and we project Androxal launch in mid-2015.” Now, Brean is citing these positive results as a reason for optimism, as well as reports that management may have interest in selling the company. Brean estimated the sell-price potentially reaching $40 a share, in the event that the sale goes down.

In addition to Andorxal, Repros currently has female reproductive drug Proellex® in the pipeline, intended for use in uterine fibroids and endometriosis. “The vaginal formulation of Proellex (Proellex-V) will enter Phase 2b in 2H13 for uterine fibroids with an NDA submission expected in 2016. All compounds are protected by U.S. patents," said Aschoff in July.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for RPRX
Lea
20 Oct 14 04:52:44
My watch: $AKS, $DUST, $AA, $COCO, $ESI, $IBIO, $KBH, $LAKE, $BBRY, $CLF, $RPRX
ApricusIR
20 Oct 14 04:50:27
$APRI Call NOW 8:00am ET regarding in-licensing of asset from Forendo Pharma for Male Urological Conditions http://t.co/r13PbOhnit $RPRX
Michele Ciani
20 Oct 14 04:41:26
$RPRX new BUY rating friday from Brean Murray. Looking for add
monestsignalen
20 Oct 14 04:22:03
Nieuwe lows voor vandaag #aandelen http://t.co/1WQWPC4ENz $RPRX $HIL $URBN
HotKeyTrading
19 Oct 14 21:30:05
Annual Lows: $HIL $PBCT $URBN $RPRX $CS $WTFC $FRC $FRAN $MWW $SLH $FCS $WGO $ICD $ERIC $STO http://t.co/Vv2VEn80mr #dow #daytrader #stock
Stockaholics
19 Oct 14 20:46:57
IBIO Closed Up 69.84% After Our Penny Stock Alert! New Picks Coming: http://t.co/OG2rloNNni $ANAC $ACTV $RPRX
HotKeyTrading
19 Oct 14 19:30:06
Gap Downs: $ATHN $MYGN $RPRX $TTPH $HMHC $ZHNE $MAT $PACD $SIAL $TS $DPZ $EXTR $KO $NFLX $DRTX http://t.co/XQITF0lRKD #swingtrading #stock
PropThinker
19 Oct 14 15:53:31
PT's weekly #biotech recap -> http://t.co/WR8cUHJU5f $SPY $TKMR $ALNY $RPRX $SPX $IWM $SHPG
BuyersStrike
19 Oct 14 15:26:44
Check out this list of $RPRX holders who think they are brilliant sector investors, while actually being dumb marks. http://t.co/sru0seJk11
BuyersStrike
19 Oct 14 15:11:26
Can we finally put to rest the "Alex Denner knows all" nonsense. Sarissa is a bagholder in $RPRX and $ARIA
HotKeyTrading
19 Oct 14 09:30:04
Annual Lows: $HIL $PBCT $URBN $RPRX $CS $WTFC $FRC $FRAN $MWW $SLH $FCS $WGO $ICD $ERIC $STO http://t.co/Vv2VEn80mr #stockpicks #daytrading
Stockaholics
19 Oct 14 09:25:31
IBIO Closed Up 69.84% After Our Penny Stock Alert! New Picks Coming: http://t.co/OG2rloNNni $ANAC $ACTV $RPRX
HotKeyTrading
19 Oct 14 07:30:04
Gap Downs: $ATHN $MYGN $RPRX $TTPH $HMHC $ZHNE $MAT $PACD $SIAL $TS $DPZ $EXTR $KO $NFLX $DRTX http://t.co/Vv2VEn80mr #trader #markets #dow
Christopher
19 Oct 14 05:10:31
RT @theflynews: $MS $GE $SRPT $RPRX $URBN $SUNE $AKS $CLF $ATHN $CYTR $AMPE $SNDK On The Fly: Pre-market Movers: Full Story http://t.co/XRt…
HotKeyTrading
18 Oct 14 21:30:05
Annual Lows: $HIL $PBCT $URBN $RPRX $CS $WTFC $FRC $FRAN $MWW $SLH $FCS $WGO $ICD $ERIC $STO http://t.co/Vv2VEn80mr #investors #watchlist
HotKeyTrading
18 Oct 14 19:30:04
Gap Downs: $ATHN $MYGN $RPRX $TTPH $HMHC $ZHNE $MAT $PACD $SIAL $TS $DPZ $EXTR $KO $NFLX $DRTX http://t.co/Vv2VEn80mr #wallstreet #spy #dow
BuyersStrike
18 Oct 14 18:06:17
@NathanAhron Any institutional manager who was long $RPRX really deserves to be fired. That right there is proof that they do no real work.
Investor Wand
18 Oct 14 18:05:57
Is $RPRX a BUY? Brean Murray, Carret & Co. thinks so:http://t.co/0yOTRSGM3A
NathanAaron
18 Oct 14 18:00:01
Oh $rprx....when will people learn....
Mark
18 Oct 14 17:45:47
RT @theflynews: $MS $GE $SRPT $RPRX $URBN $SUNE $AKS $CLF $ATHN $CYTR $AMPE $SNDK On The Fly: Pre-market Movers: Full Story http://t.co/XRt…
Dusty
18 Oct 14 16:17:45
RT @theflynews: $MS $GE $SRPT $RPRX $URBN $SUNE $AKS $CLF $ATHN $CYTR $AMPE $SNDK On The Fly: Pre-market Movers: Full Story http://t.co/XRt…
Stockaholics
18 Oct 14 13:21:20
IBIO Closed Up 69.84% After Our Penny Stock Alert! New Picks Coming: http://t.co/OG2rloNNni $ANAC $ACTV $RPRX
Jake King
18 Oct 14 13:09:10
RT @PropThinker: If you visited this week, you knew where to look for the rally. Our weekly #biotech recap -> http://t.co/eJEDOoRnNR $SPY $…
Dan
18 Oct 14 10:33:20
$RPRX Max Pain is 12.50 for maturity 10/18/2014. Last close = 6.31. http://t.co/cDsUQlgx5d
HotKeyTrading
18 Oct 14 09:30:04
Annual Lows: $HIL $PBCT $URBN $RPRX $CS $WTFC $FRC $FRAN $MWW $SLH $FCS $WGO $ICD $ERIC $STO http://t.co/Vv2VEn80mr #swingtrading #nasdaq
HotKeyTrading
18 Oct 14 07:30:04
Gap Downs: $ATHN $MYGN $RPRX $TTPH $HMHC $ZHNE $MAT $PACD $SIAL $TS $DPZ $EXTR $KO $NFLX $DRTX http://t.co/XQITF0lRKD #daytrader #spy #dow
Auto Binary option
18 Oct 14 07:10:44
RT @PropThinker: If you visited this week, you knew where to look for the rally. Our weekly #biotech recap -> http://t.co/eJEDOoRnNR $SPY $…
PropThinker
18 Oct 14 07:05:27
If you visited this week, you knew where to look for the rally. Our weekly #biotech recap -> http://t.co/eJEDOoRnNR $SPY $TKMR $ALNY $RPRX
monestsignalen
18 Oct 14 04:15:02
http://t.co/1WQWPC4ENz #aandelen nieuwe lows bij $RPRX $URBN $GTO
equities.com
18 Oct 14 03:13:09
Repros Therapeutics Inc. (RPRX) Hits New 52-week Low During October 17 Session $RPRX http://t.co/YKbIsMXvB1
TalkMarkets
18 Oct 14 03:08:45
FDA Continues To Quash Interest In Repros Therapeutics $RPRX http://t.co/z92Lc4kEOe
TalkMarkets
18 Oct 14 02:08:37
Active #Stocks: $TTPH, $RPRX, $HZNP, $THRX, $MYGN http://t.co/oD3c6jdEnJ
HotKeyTrading
17 Oct 14 21:30:06
Annual Lows: $HIL $PBCT $URBN $RPRX $CS $WTFC $FRC $FRAN $MWW $SLH $FCS $WGO $ICD $ERIC $STO http://t.co/XQITF0lRKD #finance #trader #nyse
scattercoin love
17 Oct 14 21:29:19
RT @AlertTrade: #GazerAlerts Alert results: $AHPI +5% $CPE +0% $JRJC +6% $NLNK +12% $OXF +22% $PEIX +2% $RPRX +9% $VSR +17% | via http://t.…
MAISA
17 Oct 14 21:17:17
$RPRX_$6.31_FDA has downgraded its November session with company to a Type C guidance meeting frm Type B pre-NDA meeting regarding Androxal
Scalp Trades
17 Oct 14 21:11:02
http://t.co/LGHkp3kB0r This is how we traded. $RPRX Trade Chart Analysis for Oct 17th: http://t.co/beF9kSDupX
HotKeyTrading
17 Oct 14 19:30:05
Gap Downs: $ATHN $MYGN $RPRX $TTPH $HMHC $ZHNE $MAT $PACD $SIAL $TS $DPZ $EXTR $KO $NFLX $DRTX http://t.co/Vv2VEn80mr #dow #swingtrading
Bobby Veljkovic
17 Oct 14 18:10:38
Interesting article from 2 weeks ago on $RPRX http://t.co/hdIq2oSllj
Pzaa...Guy
17 Oct 14 17:30:11
$RPRX - INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 http://t.co/1mi1yg0hXk
NASDAQ
17 Oct 14 17:30:05
$RPRX - INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 http://t.co/ln4VhYllLo
Yu Zhu
17 Oct 14 15:36:21
RT @CaptainFuture__: $RPRX Brean note: FDA Converts Androxal Meeting to Type C From The Original Type B - Not Helping The FDA (cont) http:/…
TalkMarkets
17 Oct 14 14:14:54
Active #Stocks: $TTPH, $RPRX, $HZNP, $THRX, $MYGN http://t.co/oD3c6jdEnJ
equities.com
17 Oct 14 14:12:23
Repros Therapeutics Inc. (RPRX) Drops 39.96% on October 17 $RPRX http://t.co/Wj5qpO4NJq
Scalp Trades
17 Oct 14 13:56:43
http://t.co/LGHkp3kB0r EOD result for 20 minutes of day trades for Oct 17th: $TTPH, $CMRX, $RPRX, $QLGC, $UVXY, $ESI, $IBIO, $XONE.
DeadCatBill
17 Oct 14 13:03:04
Hold $RPRX short
Day Trade Alerts
17 Oct 14 13:02:11
#GazerAlerts Alert results: $AHPI +5% $CPE +0% $JRJC +6% $NLNK +12% $OXF +22% $PEIX +2% $RPRX +9% $VSR +17% | via http://t.co/LQqutQYQ2N
Stock Horizon LLC
17 Oct 14 13:00:10
Alert results: http://t.co/poJvlIoIpz $AHPI +5% $CPE +0% $JRJC +6% $NLNK +12% $OXF +22% $PEIX +2% $RPRX +9% $VSR +17%
Livevol Community
17 Oct 14 13:00:04
Gainers: $ESI+66.25% $WLB+20.72% $TTPH+18.90% Losers: $RPRX-39.39% $APT-19.18% $URBN-14.27% Stock Movers Report: http://t.co/MImGl1GweW
RnM Enterprises
17 Oct 14 12:55:00
$RPRX... sigh... out for a loss on this one...
MAISA
17 Oct 14 12:50:02
$RPRX could be a perfect storm to SURF
				
				
By  +Follow September 17, 2013 8:01AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.